GSS vs HLS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

GSS

GENETICSIG FPO [GSS]

54MEDIUM

HLS

HEALIUS FPO [HLS]

54MEDIUM

Score Breakdown

GSS HLS
Technical
50
68
Catalyst
65
87
Sentiment
50
50
Fundamental
59
90
Momentum
31
34
Risk Gate
50
32

Key Metrics

GSS Metric HLS
$14.5MMarket Cap$275.9M
877KAvg Volume (20d)4.3M
N/AShort Interest+10.1%
$0.43052-Week High$1.070
$0.05752-Week Low$0.300
-1.6%Daily Change+3.2%
$0.063Reference Price$0.392
-22.8%ROE-69.3%
-56.5%Profit Margin-12.3%

Active Signals

GSS Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (12 quarters)
Low P/S ratio (0.7x)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

HLS Signals

MACD momentum is picking up steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.2x)
EPS estimates revised upward (+10pts)
Near 52-week low (10% of range)

Ask Scout AI to compare GSS and HLS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ATX vs GSS →AVE vs PNV →ACL vs AVE →AVE vs PYC →ACL vs PNV →
GSS Full Analysis → HLS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).